WX-024

N/A

Report date: 2025/01/26 17:14:23

Base Information

Drug NameWX-024
Drug Alias NameWnt pathway inhibitors (WntRx Pharmaceuticals)beta-catenin inhibitors (WntRx Pharmaceuticals)WX-024
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWntRx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWntRx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A